Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (29)

Search Parameters:
Keywords = respiratory contagious illness

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
22 pages, 2066 KiB  
Article
Forecasting Influenza Trends Using Decomposition Technique and LightGBM Optimized by Grey Wolf Optimizer Algorithm
by Yonghui Duan, Chen Li, Xiang Wang, Yibin Guo and Hao Wang
Mathematics 2025, 13(1), 24; https://doi.org/10.3390/math13010024 - 25 Dec 2024
Viewed by 697
Abstract
Influenza is an acute respiratory infectious disease marked by its high contagiousness and rapid spread, caused by influenza viruses. Accurate influenza prediction is a critical issue in public health and serves as an essential tool for epidemiological studies. This paper seeks to improve [...] Read more.
Influenza is an acute respiratory infectious disease marked by its high contagiousness and rapid spread, caused by influenza viruses. Accurate influenza prediction is a critical issue in public health and serves as an essential tool for epidemiological studies. This paper seeks to improve the prediction accuracy of influenza-like illness (ILI) proportions by proposing a novel predictive model that integrates a data decomposition technique with the Grey Wolf Optimizer (GWO) algorithm, aiming to overcome the limitations of current prediction methods. Firstly, the most suitable indicators were selected using Spearman correlation coefficient. Secondly, a GWO-LightGBM model was established to obtain the residuals between the predicted and actual values. The residual sequence from the GWO-LightGBM model was then decomposed and corrected using the Complete Ensemble Empirical Mode Decomposition with Adaptive Noise (CEEMDAN) method, which led to the development of the GWO-LightGBM-CEEMDAN model. The incorporation of the Baidu Index was shown to enhance the precision of the proposed model’s predictions. The proposed model outperforms comparison models in terms of evaluation metrics such as RMSE and MAPE. Additionally, our study found that the revised Baidu Index indicators show a notable association with ILI trends. Full article
Show Figures

Figure 1

16 pages, 2785 KiB  
Systematic Review
Systematic Review on Influenza Burden in Emerging Markets in 2018–2023—An Evidence Update to Guide Influenza Vaccination Recommendations
by Moe H. Kyaw, Sophie Bozhi Chen, Shishi Wu, Chee Yoong Foo, Verna Welch, Constantina Boikos and Oladayo Jagun
Vaccines 2024, 12(11), 1251; https://doi.org/10.3390/vaccines12111251 - 2 Nov 2024
Cited by 1 | Viewed by 1906
Abstract
Background: Influenza is a contagious respiratory illness responsible for seasonal epidemics and with potential to cause pandemics. The decline in influenza-related studies published since 2018 resulted in data gaps, particularly in emerging markets. Methods: This systematic review searched for studies in six databases [...] Read more.
Background: Influenza is a contagious respiratory illness responsible for seasonal epidemics and with potential to cause pandemics. The decline in influenza-related studies published since 2018 resulted in data gaps, particularly in emerging markets. Methods: This systematic review searched for studies in six databases and gray literature sources to define the clinical burden of influenza and influenza-like illness (ILIs) and their associated sequelae among humans across emerging markets. Eligible studies were published in English, Spanish, or Chinese between January 2018 and September 2023 and conducted in Asia, the Middle East, Africa, and Latin America. Results: In total, 256 articles were included, mostly on lab-confirmed influenza infections (n = 218). Incidences of lab-confirmed influenza cases in Asia (range 540–1279 cases/100,000 persons) and Sub-Saharan Africa (range 34,100–47,800 cases/100,000 persons) were higher compared to Latin America (range 0.7–112 cases/100,000 persons) and the Middle East and North Africa (range 0.1–10 cases/100,000 persons). Proportions of lab-confirmed influenza cases and influenza-associated outcomes (i.e., hospitalization, ICU admission and death) varied widely across regions. Temporal variation in influenza trend was observed before and during the COVID-19 pandemic. Conclusions: In conclusion, influenza causes significant disease burden in emerging markets. Robust large real-world studies using a similar methodology are needed to have more accurate estimates and compare studies within age groups and regions. Continuous monitoring of influenza epidemiology is important to inform vaccine programs in emerging markets with heavy influenza disease burden. Full article
(This article belongs to the Section Epidemiology and Vaccination)
Show Figures

Figure 1

16 pages, 2249 KiB  
Article
Integrating Genomic, Climatic, and Immunological Factors to Analyze Seasonal Patterns of Influenza Variants
by Anass Bouchnita and Behzad Djafari-Rouhani
Symmetry 2024, 16(8), 943; https://doi.org/10.3390/sym16080943 - 23 Jul 2024
Cited by 2 | Viewed by 1701
Abstract
Influenza, often referred to as the flu, is an extremely contagious respiratory illness caused by influenza viruses, impacting populations globally with significant health consequences annually. A hallmark of influenza is its seasonal patterns, influenced by a mix of geographic, evolutionary, immunological, and environmental [...] Read more.
Influenza, often referred to as the flu, is an extremely contagious respiratory illness caused by influenza viruses, impacting populations globally with significant health consequences annually. A hallmark of influenza is its seasonal patterns, influenced by a mix of geographic, evolutionary, immunological, and environmental factors. Understanding these seasonal trends is crucial for informing public health decisions, including the planning of vaccination campaigns and their formulation. In our study, we introduce a genotype-structured infectious disease model for influenza transmission, immunity, and evolution. In this model, the population of infected individuals is structured according to the virus they harbor. It considers a symmetrical fitness landscape where the influenza A and B variants are considered. The model incorporates the effects of population immunity, climate, and epidemic heterogeneity, which makes it suitable for investigating influenza seasonal dynamics. We parameterize the model to the genomic surveillance data of flu in the US and use numerical simulations to elucidate the scenarios that result in the alternating or consecutive prevalence of flu variants. We show that the speed of virus evolution determines the alternation and co-circulation patterns of seasonal influenza. Our simulations indicate that slow immune waning reduces how often variants change, while cross-immunity regulates the co-circulation of variants. The framework can be used to predict the composition of future influenza outbreaks and guide the development of cocktail vaccines and antivirals that mitigate influenza in both the short and long term. Full article
(This article belongs to the Special Issue Mathematical Modeling in Biology and Life Sciences)
Show Figures

Figure 1

14 pages, 2037 KiB  
Article
Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge
by Nisha Kannan, Annette Choi, Mariela A. Rivera De Jesus, Peter Male Wei, Julie Marie Sahler, Stephanie Marie Curley, Avery August, Matthew P. DeLisa, Gary R. Whittaker and David Putnam
Vaccines 2024, 12(7), 724; https://doi.org/10.3390/vaccines12070724 - 29 Jun 2024
Cited by 1 | Viewed by 2320
Abstract
Influenza is a highly contagious respiratory disease, resulting in an estimated 3 to 5 million cases of severe illness annually. While most influenza vaccines are administered parenterally via injection, one shortcoming is that they do not generate a strong immune response at the [...] Read more.
Influenza is a highly contagious respiratory disease, resulting in an estimated 3 to 5 million cases of severe illness annually. While most influenza vaccines are administered parenterally via injection, one shortcoming is that they do not generate a strong immune response at the site of infection, which can become important in a pandemic. Intranasal vaccines can generate both local and systemic protective immune responses, can reduce costs, and enhance ease of administration. Previous studies showed that parenterally administered outer membrane vesicles (OMVs) that carry sequences of the M2e protein (OMV-M2e) protect against influenza A/PR8 challenge in mice and ferrets. In the current study, we measured the effectiveness of the intranasal route of the OMV-M2e vaccine against the influenza A/PR8 strain in mice. We observed high anti-M2e IgG and IgA titers post-challenge in mice vaccinated intranasally with OMV-M2e. In addition, we observed a Th1/Tc1 bias in the vaccinated mice, and an increased Th17/Tc17 response, both of which correlated with survival to A/PR8 challenge and significantly lower lung viral titers. We conclude that the intranasal-route administration of the OMV-M2e vaccine is a promising approach toward generating protection against influenza A as it leads to an increased proinflammatory immune response correlating with survival to viral challenge. Full article
(This article belongs to the Special Issue Nanoparticle Formulated Vaccines: Opportunities and Challenges)
Show Figures

Figure 1

17 pages, 1223 KiB  
Review
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza
by Eliel Nham, Ji Yun Noh, Ok Park, Won Suk Choi, Joon Young Song, Hee Jin Cheong and Woo Joo Kim
Vaccines 2024, 12(5), 514; https://doi.org/10.3390/vaccines12050514 - 9 May 2024
Cited by 2 | Viewed by 2381
Abstract
Coronavirus disease 2019 (COVID-19) is a highly contagious zoonotic respiratory disease with many similarities to influenza. Effective vaccines are available for both; however, rapid viral evolution and waning immunity make them virtually impossible to eradicate with vaccines. Thus, the practical goal of vaccination [...] Read more.
Coronavirus disease 2019 (COVID-19) is a highly contagious zoonotic respiratory disease with many similarities to influenza. Effective vaccines are available for both; however, rapid viral evolution and waning immunity make them virtually impossible to eradicate with vaccines. Thus, the practical goal of vaccination is to reduce the incidence of serious illnesses and death. Three years after the introduction of COVID-19 vaccines, the optimal vaccination strategy in the endemic period remains elusive, and health authorities worldwide have begun to adopt various approaches. Herein, we propose a COVID-19 vaccination strategy based on the data available until early 2024 and discuss aspects that require further clarification for better decision making. Drawing from comparisons between COVID-19 and influenza vaccination strategies, our proposed COVID-19 vaccination strategy prioritizes high-risk groups, emphasizes seasonal administration aligned with influenza vaccination campaigns, and advocates the co-administration with influenza vaccines to increase coverage. Full article
(This article belongs to the Special Issue COVID-19 and Vaccination Strategies in Global Health)
Show Figures

Figure 1

11 pages, 1045 KiB  
Article
Influenza A and B Viruses in Fine Aerosols of Exhaled Breath Samples from Patients in Tropical Singapore
by Vincent T. K. Chow, Douglas Jie Wen Tay, Mark I. C. Chen, Julian W. Tang, Donald K. Milton and Kwok Wai Tham
Viruses 2023, 15(10), 2033; https://doi.org/10.3390/v15102033 - 30 Sep 2023
Cited by 5 | Viewed by 2427
Abstract
Influenza is a highly contagious respiratory illness that commonly causes outbreaks among human communities. Details about the exact nature of the droplets produced by human respiratory activities such as breathing, and their potential to carry and transmit influenza A and B viruses is [...] Read more.
Influenza is a highly contagious respiratory illness that commonly causes outbreaks among human communities. Details about the exact nature of the droplets produced by human respiratory activities such as breathing, and their potential to carry and transmit influenza A and B viruses is still not fully understood. The objective of our study was to characterize and quantify influenza viral shedding in exhaled aerosols from natural patient breath, and to determine their viral infectivity among participants in a university cohort in tropical Singapore. Using the Gesundheit-II exhaled breath sampling apparatus, samples of exhaled breath of two aerosol size fractions (“coarse” > 5 µm and “fine” ≤ 5 µm) were collected and analyzed from 31 study participants, i.e., 24 with influenza A (including H1N1 and H3N2 subtypes) and 7 with influenza B (including Victoria and Yamagata lineages). Influenza viral copy number was quantified using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Infectivity of influenza virus in the fine particle fraction was determined by culturing in Madin–Darby canine kidney cells. Exhaled influenza virus RNA generation rates ranged from 9 to 1.67 × 105 and 10 to 1.24 × 104 influenza virus RNA copies per minute for the fine and coarse aerosol fractions, respectively. Compared to the coarse aerosol fractions, influenza A and B viruses were detected more frequently in the fine aerosol fractions that harbored 12-fold higher viral loads. Culturable virus was recovered from the fine aerosol fractions from 9 of the 31 subjects (29%). These findings constitute additional evidence to reiterate the important role of fine aerosols in influenza transmission and provide a baseline range of influenza virus RNA generation rates. Full article
(This article belongs to the Special Issue Animal and Human Respiratory Viruses—Causes of the Next Pandemic?)
Show Figures

Figure 1

18 pages, 13421 KiB  
Article
Diagnostic Performance of the Radiological Society of North America Consensus Statement for Reporting COVID-19 Chest CT Findings: A Revisit
by Mohammed Hazem, Sayed Ibrahim Ali, Qasem M. AlAlwan, Ibrahim Khalid Al Jabr, Sarah Abdulrahman F. Alshehri, Mohammed Q. AlAlwan, Mohammed Ibrahim Alsaeed, Mohammed Aldawood, Jamela A. Turkistani and Yasser Abdelkarim Amin
J. Clin. Med. 2023, 12(16), 5180; https://doi.org/10.3390/jcm12165180 - 9 Aug 2023
Cited by 1 | Viewed by 1539
Abstract
Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease that leads to variable degrees of illness, and which may be fatal. We evaluated the diagnostic performance of each chest computed tomography (CT) reporting category recommended by the Expert Consensus of the Radiological [...] Read more.
Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease that leads to variable degrees of illness, and which may be fatal. We evaluated the diagnostic performance of each chest computed tomography (CT) reporting category recommended by the Expert Consensus of the Radiological Society of North America (RSNA) in comparison with that of reverse transcription polymerase chain reaction (RT-PCR). We aimed to add an analysis of this form of reporting in the Middle East, as few studies have been performed there. Between July 2021 and February 2022, 184 patients with a mean age of 55.56 ± 16.71 years and probable COVID-19 infections were included in this retrospective study. Approximately 64.67% (119 patients) were male, while 35.33% (65 patients) were female. Within 7 days, all patients underwent CT and RT-PCR examinations. According to a statement by the RSNA, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of each CT reporting category were calculated, and the RT-PCR results were used as a standard reference. The RT-PCR results confirmed a final diagnosis of COVID-19 infection in 60.33% of the patients. For COVID-19 diagnoses, the typical category (n = 88) had a sensitivity, specificity, PPV, and accuracy of 74.8%, 93.2%, 94.3%, and 92.5%, respectively. For non-COVID-19 diagnoses, the PPVs for the atypical (n = 22) and negative (n = 46) categories were 81.8% and 89.1%, respectively. The PPV for the indeterminate (n = 28) category was 67.9%, with a low sensitivity of 17.1%. However, the RSNA’s four chest CT reporting categories provide a strong diagnostic foundation and are highly correlated with the RT-PCR results for the typical, atypical, and negative categories, but they are weaker for the indeterminate category. Full article
(This article belongs to the Section Nuclear Medicine & Radiology)
Show Figures

Figure 1

14 pages, 2991 KiB  
Article
In Vitro Characterization of chIFITMs of Aseel and Kadaknath Chicken Breeds against Newcastle Disease Virus Infection
by Muthusamy Malarmathi, Nagarajan Murali, Mani Selvaraju, Karuppusamy Sivakumar, Vasudevan Gowthaman, Vadivel Balasubramanian Raghavendran, Angamuthu Raja, Sunday O. Peters and Aranganoor Kannan Thiruvenkadan
Biology 2023, 12(7), 919; https://doi.org/10.3390/biology12070919 - 27 Jun 2023
Cited by 3 | Viewed by 2051
Abstract
Newcastle disease (ND) is highly contagious and usually causes severe illness that affects Aves all over the world, including domestic poultry. Depending on the virus’s virulence, it can impact the nervous, respiratory, and digestive systems and cause up to 100% mortality. The chIFITM [...] Read more.
Newcastle disease (ND) is highly contagious and usually causes severe illness that affects Aves all over the world, including domestic poultry. Depending on the virus’s virulence, it can impact the nervous, respiratory, and digestive systems and cause up to 100% mortality. The chIFITM genes are activated in response to viral infection. The current study was conducted to quantify the mRNA of chIFITM genes in vitro in response to ND viral infection. It also examined its ability to inhibit ND virus replication in chicken embryo fibroblast (CEF) cells of the Aseel and Kadaknath breeds. Results from the study showed that the expression of all chIFITM genes was significantly upregulated throughout the period in the infected CEF cells of both breeds compared to uninfected CEF cells. In CEF cells of the Kadaknath breed, elevated levels of expression of the chIFITM3 gene dramatically reduced ND viral growth, and the viral load was 60% lower than in CEF cells of the Aseel breed. The expression level of the chIFITMs in Kadaknath ranged from 2.39 to 11.68 log2 folds higher than that of control CEFs and was consistently (p < 0.01) higher than Aseel CEFs. Similar to this, theIFN-γ gene expresses strongly quickly and peaks at 13.9 log2 fold at 48 hpi. Based on these cellular experiments, the Kadaknath breed exhibits the potential for greater disease tolerance than Aseel. However, to gain a comprehensive understanding of disease resistance mechanisms in chickens, further research involving in vivo investigations is crucial. Full article
(This article belongs to the Section Infection Biology)
Show Figures

Figure 1

13 pages, 2163 KiB  
Article
Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model
by Hariprasad Thangavel, Dhanya Dhanyalayam, Kezia Lizardo, Neelam Oswal, Enriko Dolgov, David S. Perlin and Jyothi F. Nagajyothi
Int. J. Mol. Sci. 2023, 24(2), 1314; https://doi.org/10.3390/ijms24021314 - 9 Jan 2023
Cited by 7 | Viewed by 3570
Abstract
The coronavirus disease (COVID-19) is a highly contagious viral illness caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 has had a catastrophic effect globally causing millions of deaths worldwide and causing long-lasting health complications in COVID-19 survivors. Recent studies including ours have [...] Read more.
The coronavirus disease (COVID-19) is a highly contagious viral illness caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 has had a catastrophic effect globally causing millions of deaths worldwide and causing long-lasting health complications in COVID-19 survivors. Recent studies including ours have highlighted that adipose tissue can act as a reservoir where SARS-CoV-2 can persist and cause long-term health problems. Here, we evaluated the effect of SARS-CoV-2 infection on adipose tissue physiology and the pathogenesis of fat loss in a murine COVID-19 model using humanized angiotensin-converting enzyme 2 (hACE2) mice. Since epidemiological studies reported a higher mortality rate of COVID-19 in males than in females, we examined hACE2 mice of both sexes and performed a comparative analysis. Our study revealed for the first time that: (a) viral loads in adipose tissue and the lungs differ between males and females in hACE2 mice; (b) an inverse relationship exists between the viral loads in the lungs and adipose tissue, and it differs between males and females; and (c) CoV-2 infection alters immune signaling and cell death signaling differently in SARS-CoV-2 infected male and female mice. Overall, our data suggest that adipose tissue and loss of fat cells could play important roles in determining susceptibility to CoV-2 infection in a sex-dependent manner. Full article
(This article belongs to the Special Issue The Twist and Turn of Lipids in Human Diseases)
Show Figures

Figure 1

22 pages, 7797 KiB  
Article
Public Behavior in Urban Parks during Pandemics as a Foundation for Risk Assessment by Park Managers: A Case Study in Saudi Arabia
by Farouk Daghistani
Sustainability 2023, 15(2), 904; https://doi.org/10.3390/su15020904 - 4 Jan 2023
Cited by 1 | Viewed by 2265
Abstract
Accessing parks without transmitting viruses would ensure not depriving people of parks’ health benefits during pandemics. This study attempts to develop a practical tool for park managers to assess the risk of contracting respiratory contagious illnesses, decide on meaningful mitigation measures, and monitor [...] Read more.
Accessing parks without transmitting viruses would ensure not depriving people of parks’ health benefits during pandemics. This study attempts to develop a practical tool for park managers to assess the risk of contracting respiratory contagious illnesses, decide on meaningful mitigation measures, and monitor the effect of these measures. The assessment is based on the spatial and temporal behaviors of users at each park open space type (POST), particularly the behaviors that may impact the risk of illness transmission. The researcher created a checklist, including five factors relating to users: physical distancing, density, duration of stay, percentage of users wearing masks, and frequency of surface touch; then, the implementation of the tool was demonstrated by selecting a sample zone from Jeddah waterfront park, Saudi Arabia, while COVID-19 was active. User behavior data were collected at the POSTs of the sample zone, using behavioral mapping and tracking methods. After analyzing the data using ArcGIS Desktop and SPSS Statistics software, the data were used to fill out the composed checklist to assess the risk at POSTs. The findings indicated that the waterfront railing area, playground, and pier were the POSTs with the highest risk. By using the checklist, park managers can contribute to the success of non-pharmaceutical mitigation interventions at a local scale. Full article
Show Figures

Figure 1

21 pages, 14593 KiB  
Article
Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients
by Yu Chen, Yujia Qin, Yuanyuan Fu, Zitong Gao and Youping Deng
Int. J. Mol. Sci. 2022, 23(24), 15698; https://doi.org/10.3390/ijms232415698 - 10 Dec 2022
Cited by 3 | Viewed by 3976
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious and pathogenic coronavirus that emerged in late 2019 and caused a pandemic of respiratory illness termed as coronavirus disease 2019 (COVID-19). Cancer patients are more susceptible to SARS-CoV-2 infection. The treatment of [...] Read more.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious and pathogenic coronavirus that emerged in late 2019 and caused a pandemic of respiratory illness termed as coronavirus disease 2019 (COVID-19). Cancer patients are more susceptible to SARS-CoV-2 infection. The treatment of cancer patients infected with SARS-CoV-2 is more complicated, and the patients are at risk of poor prognosis compared to other populations. Patients infected with SARS-CoV-2 are prone to rapid development of acute respiratory distress syndrome (ARDS) of which pulmonary fibrosis (PF) is considered a sequelae. Both ARDS and PF are factors that contribute to poor prognosis in COVID-19 patients. However, the molecular mechanisms among COVID-19, ARDS and PF in COVID-19 patients with cancer are not well-understood. In this study, the common differentially expressed genes (DEGs) between COVID-19 patients with and without cancer were identified. Based on the common DEGs, a series of analyses were performed, including Gene Ontology (GO) and pathway analysis, protein–protein interaction (PPI) network construction and hub gene extraction, transcription factor (TF)–DEG regulatory network construction, TF–DEG–miRNA coregulatory network construction and drug molecule identification. The candidate drug molecules (e.g., Tamibarotene CTD 00002527) obtained by this study might be helpful for effective therapeutic targets in COVID-19 patients with cancer. In addition, the common DEGs among ARDS, PF and COVID-19 patients with and without cancer are TNFSF10 and IFITM2. These two genes may serve as potential therapeutic targets in the treatment of COVID-19 patients with cancer. Changes in the expression levels of TNFSF10 and IFITM2 in CD14+/CD16+ monocytes may affect the immune response of COVID-19 patients. Specifically, changes in the expression level of TNFSF10 in monocytes can be considered as an immune signature in COVID-19 patients with hematologic cancer. Targeting N6-methyladenosine (m6A) pathways (e.g., METTL3/SERPINA1 axis) to restrict SARS-CoV-2 reproduction has therapeutic potential for COVID-19 patients. Full article
(This article belongs to the Special Issue Cancer Biomarkers and Bioinformatics)
Show Figures

Figure 1

15 pages, 1500 KiB  
Review
Respiratory Syncytial Virus: An Uncommon Cause of Febrile Seizures—Results from a Systematic Review and Meta-Analysis
by Matteo Riccò, Milena Pia Cerviere, Silvia Corrado, Silvia Ranzieri and Federico Marchesi
Pediatr. Rep. 2022, 14(4), 464-478; https://doi.org/10.3390/pediatric14040055 - 2 Nov 2022
Cited by 7 | Viewed by 3171
Abstract
Human Respiratory Syncytial Virus (RSV) is a highly contagious viral pathogen. In infants, it is usually listed among the main causes of medical referrals and hospitalizations, particularly among newborns, and a considerable base of evidence associates RSV infections and bronchiolitis with long-term neurological [...] Read more.
Human Respiratory Syncytial Virus (RSV) is a highly contagious viral pathogen. In infants, it is usually listed among the main causes of medical referrals and hospitalizations, particularly among newborns, and a considerable base of evidence associates RSV infections and bronchiolitis with long-term neurological sequelae. We specifically performed a systematic review and meta-analysis in order to ascertain whether RSV infections may be associated with an increased risk for febrile seizures (FS) in infected infants. According to the PRISMA statement, Pubmed, Embase, and pre-print archive medRxiv.og were searched for eligible observational studies published up to 1 July 2022. Raw data included the incidence of FS among children admitted for influenza-like illness (ILI) and/or bronchiolitis, with a confirmed diagnosis of RSV or seasonal influenza virus (SIV) infection. Data were then pooled in a random-effects model. Heterogeneity was assessed using the I2 measure, while reporting bias was assessed by means of funnel plots and regression analysis. A total of 11 studies including 6847 cases of RSV infections were retrieved, with a pooled prevalence of 29.975 cases of FS per 1000 RSV cases (I2 = 88.5%). The prevalence was not substantially greater in studies performed in pediatric intensive care units (53.817 per 1000 RSV cases vs. 23.552, p = 0.12). Higher occurrence of FS was reported from studies performed after 2010 (Risk Ratio [RR] 1.429, 95% Confidence Interval [95%CI] 1.049–1.948), and in China (RR 2.105, 95%CI 1.356–3.266) and South Africa (RR 1.722, 95%CI 1.060–2.824) than in Europe, while a lower occurrence was reported form the USA (RR 0.414, 95%CI 0.265–0.649). Eventually, FS were less likely reported from RSV cases compared to subjects affected by seasonal influenza (RR 0.402; 95%CI 0.228–0.708). Although RSV is often associated with high risk of neurological complications, substantially less cases of FS are reported than in SIV infections. However, the paucity of available studies recommends a cautious appraisal of aforementioned results. Full article
Show Figures

Figure 1

13 pages, 308 KiB  
Article
Health Consequences of Overexposure to Disinfectants and Self-Medication against SARS-CoV-2: A Cautionary Tale Review
by Hassan Hashemi, Shiva Ghareghani, Nasrin Nasimi, Mohammad Shahbazi, Zahra Derakhshan and Samuel Asumadu Sarkodie
Sustainability 2022, 14(20), 13614; https://doi.org/10.3390/su142013614 - 20 Oct 2022
Cited by 4 | Viewed by 4568
Abstract
To control and prevent the spread of the infectious agents in the environment and body, various measures have been taken, including the use of disinfectants for hands and surfaces, use of detergents, self-medication by herbal concoctions, and dietary supplements. Although these actions may [...] Read more.
To control and prevent the spread of the infectious agents in the environment and body, various measures have been taken, including the use of disinfectants for hands and surfaces, use of detergents, self-medication by herbal concoctions, and dietary supplements. Although these actions may have a therapeutic effect or reduce the viral load, incorrect use (abuse or overuse) could have negative health repercussions. Therefore, public awareness in this context is essential. The purpose of this narrative review was to evaluate the health consequences of overexposure to disinfectants and self-medication against infectious agents, specially SARS-CoV-2. The literature search for this review was conducted using related keywords in PubMed, Web of Science (WOS), and Scopus databases. This review found a significant number of reported poisoning cases during the pandemic as a result of the overuse of alcoholic hand sanitizers, household bleach products, and detergents. This paper also provides an integrated systemic overview of the possible toxic effects of self-medication, alcohol consumption, and self-administration of dietary supplements and herbs during the COVID-19 pandemic. The present review indicated that the main adverse effects associated with the overuse of popular preventative actions against contagious respiratory illnesses specially COVID-19 and Influenza (flu) were methanol intoxication, skin damage, respiratory problems, gastrointestinal ulcers, nausea, vomiting, epigastric pain, and liver injury. Due to the significant increase in the use of these preventative measures, it is essential to raise public awareness of the side effects of their excessive and unnecessary use. Full article
(This article belongs to the Collection Impact of COVID-19 on the Environment, Energy and Economics)
15 pages, 1902 KiB  
Article
Epidemiological and Phylogeographic Study of Equid Herpesviruses in Tunisia
by Chaima Badr, Oussama Souiai, Marwa Arbi, Imen El Behi, Mohamed S. Essaied, Ines Khosrof, Alia Benkahla, Ahmed Chabchoub and Abdeljelil Ghram
Pathogens 2022, 11(9), 1016; https://doi.org/10.3390/pathogens11091016 - 5 Sep 2022
Cited by 4 | Viewed by 2557
Abstract
Equid herpesvirus (EHV) is a contagious viral disease affecting horses, causing illness characterized by respiratory symptoms, abortion and neurological disorders. It is common worldwide and causes severe economic losses to the equine industry. The present study was aimed at investigating the incidence of [...] Read more.
Equid herpesvirus (EHV) is a contagious viral disease affecting horses, causing illness characterized by respiratory symptoms, abortion and neurological disorders. It is common worldwide and causes severe economic losses to the equine industry. The present study was aimed at investigating the incidence of EHVs, the genetic characterization of Tunisian isolates and a spatiotemporal study, using 298 collected samples from diseased and clinically healthy horses. The global incidence of EHV infection was found to be about 71.81%. EHV2 and EHV5 were detected in 146 (48.99%) and 159 (53.35%) sampled horses, respectively. EHV1 was detected in 11 samples (3.69%); EHV4 was not detected. Co-infections with EHV1-EHV2, EHV1-EHV5 and EHV2-EHV5 were observed in 0.33%, 1.34% and 31.54% of tested horses, respectively. Phylogenetic analyses showed that gB of EHV2 and EHV5 displays high genetic diversity with a nucleotide sequence identity ranging from 88 to 100% for EHV2 and 97.5 to 100% for EHV5. Phylogeography suggested Iceland and USA as the most likely countries of origin of the Tunisian EHV2 and EHV5 isolates. These viruses detected in Tunisia seemed to be introduced in the 2000s. This first epidemiological and phylogeographic study is important for better knowledge of the evolution of equid herpesvirus infections in Tunisia. Full article
(This article belongs to the Topic Acute Respiratory Viruses Molecular Epidemiology)
Show Figures

Figure 1

21 pages, 1112 KiB  
Review
Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
by Aram Yegiazaryan, Arbi Abnousian, Logan J. Alexander, Ali Badaoui, Brandon Flaig, Nisar Sheren, Armin Aghazarian, Dijla Alsaigh, Arman Amin, Akaash Mundra, Anthony Nazaryan, Frederick T. Guilford and Vishwanath Venketaraman
Int. J. Mol. Sci. 2022, 23(16), 9297; https://doi.org/10.3390/ijms23169297 - 18 Aug 2022
Cited by 10 | Viewed by 3513
Abstract
Coronaviruses represent a diverse family of enveloped positive-sense single stranded RNA viruses. COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus-2, is a highly contagious respiratory disease transmissible mainly via close contact and respiratory droplets which can result in severe, life-threatening respiratory pathologies. It [...] Read more.
Coronaviruses represent a diverse family of enveloped positive-sense single stranded RNA viruses. COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus-2, is a highly contagious respiratory disease transmissible mainly via close contact and respiratory droplets which can result in severe, life-threatening respiratory pathologies. It is understood that glutathione, a naturally occurring antioxidant known for its role in immune response and cellular detoxification, is the target of various proinflammatory cytokines and transcription factors resulting in the infection, replication, and production of reactive oxygen species. This leads to more severe symptoms of COVID-19 and increased susceptibility to other illnesses such as tuberculosis. The emergence of vaccines against COVID-19, usage of monoclonal antibodies as treatments for infection, and implementation of pharmaceutical drugs have been effective methods for preventing and treating symptoms. However, with the mutating nature of the virus, other treatment modalities have been in research. With its role in antiviral defense and immune response, glutathione has been heavily explored in regard to COVID-19. Glutathione has demonstrated protective effects on inflammation and downregulation of reactive oxygen species, thereby resulting in less severe symptoms of COVID-19 infection and warranting the discussion of glutathione as a treatment mechanism. Full article
Show Figures

Figure 1

Back to TopTop